Suppr超能文献

具有骨髓和脾脏重建能力且在第16天、12天和8天形成脾脏集落的细胞,根据罗丹明123保留量的增加依次排序。

Cells with marrow and spleen repopulating ability and forming spleen colonies on day 16, 12, and 8 are sequentially ordered on the basis of increasing rhodamine 123 retention.

作者信息

Ploemacher R E, Brons N H

机构信息

Department of Cell Biology and Genetics, Erasmus University, Rotterdam, The Netherlands.

出版信息

J Cell Physiol. 1988 Sep;136(3):531-6. doi: 10.1002/jcp.1041360320.

Abstract

Mouse bone marrow cells (BMC) were subjected to countercurrent centrifugal elutriation and subsequently separated on the basis of light scatter and fluorescence intensity after being labeled with the supravital dye Rhodamine 123 (Rh-123). The sorted cells were then assayed for their in vivo spleen colony-forming ability (day -8, -12, and -16 CFU-S) and their ability to repopulate the bone marrow or spleen over a 13-day period with CFU-S-12, CFU-GM, or nucleated cells. Cells with marrow repopulating ability (MRA), as measured by the ability of the sorted cells to repopulate the marrow with secondary CFU-S-12 or CFU-GM, had low affinity for Rh-123. These cells showed minimal spleen colony-forming ability, and the ratio of MRA to CFU-S-12 in this preparation was 309. Cells with spleen repopulating ability (SRA), CFU-S-16, CFU-S-12, and CFU-S-8 retained increasing amounts of Rh-123, respectively, and CFU-S-8 were almost exclusively found among cells with high Rh-123 affinity. These cells also included about half of all day-12 CFU-S, and the ratio of MRA to day-12 CFU-S was 0. The results show that MRA cells, SRA cells, CFU-S-16, CFU-S-12, and CFU-S-8 can be sequentially ordered on the basis of increasing mitochondrial activity. The data also demonstrate for the first time, and without the application of negative selection by the use of cytostatic agents, that MRA cells are a separate class of primitive hemopoietic stem cells that fully meet the criteria of pre-CFU-S.

摘要

将小鼠骨髓细胞(BMC)进行逆流离心淘析,随后用活体染料罗丹明123(Rh - 123)标记后,根据光散射和荧光强度进行分离。然后对分选的细胞进行体内脾集落形成能力检测(第 - 8、 - 12和 - 16天的CFU - S),以及在13天内用CFU - S - 12、CFU - GM或有核细胞重新填充骨髓或脾脏的能力检测。通过分选细胞用二级CFU - S - 12或CFU - GM重新填充骨髓的能力来衡量,具有骨髓重建能力(MRA)的细胞对Rh - 123的亲和力较低。这些细胞显示出最小的脾集落形成能力,并且该制剂中MRA与CFU - S - 12的比例为309。具有脾重建能力(SRA)的细胞、CFU - S - 16、CFU - S - 12和CFU - S - 8分别保留了越来越多的Rh - 123,并且CFU - S - 8几乎只存在于具有高Rh - 123亲和力的细胞中。这些细胞还包括所有第12天CFU - S的约一半,并且MRA与第12天CFU - S的比例为0。结果表明,MRA细胞、SRA细胞、CFU - S - 16、CFU - S - 12和CFU - S - 8可以根据线粒体活性的增加依次排序。数据还首次证明,在不使用细胞抑制剂进行阴性选择的情况下,MRA细胞是一类单独的原始造血干细胞,完全符合前CFU - S的标准。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验